• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于生成用于控释药物的稳定聚合物纳米颗粒的高效微流体混合系统的应用

The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.

作者信息

Morikawa Yoshinori, Tagami Tatsuaki, Hoshikawa Akihiro, Ozeki Tetsuya

机构信息

Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University.

出版信息

Biol Pharm Bull. 2018;41(6):899-907. doi: 10.1248/bpb.b17-01036.

DOI:10.1248/bpb.b17-01036
PMID:29863078
Abstract

Microfluidics is a promising system for efficiently optimizing the experimental conditions for preparing nanomedicines, such as self-assembled nanoparticles. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles are promising drug carriers allowing sustained drug release. Here, we encapsulated the model drug curcumin, which has many pharmacological activities, into PLGA nanoparticles and investigated the effects of experimental conditions on the resulting PLGA nanoparticles using a microfluidics system with a staggered herringbone structure that can stir solutions through chaotic advection. The total flow rate and flow rate ratio of the solutions in the microfluidics system affected the diameters, polydispersity index, and encapsulation efficiency of the resulting PLGA nanoparticles and produced small, homogenous PLGA nanoparticles. The incorporation of polyethylene glycol (PEG)-PLGA into the PLGA nanoparticles reduced the particle size and improved the encapsulation efficiency. Initial burst release from the PLGA nanoparticles was prevented by the incorporation of PEG2000-PLGA. Curcumin-loaded PEGylated PLGA nanoparticles showed cytotoxicity similar to that of other formulations. This microfluidics system allows high throughput and is scalable for the efficient preparation of PLGA nanoparticles and PEGylated PLGA nanoparticles. Our results will be useful for developing novel PLGA-based polymer nanoparticles by using the microfluidics.

摘要

微流控技术是一种很有前景的系统,可有效优化制备纳米药物(如自组装纳米颗粒)的实验条件。聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒是很有前景的药物载体,可实现药物的持续释放。在此,我们将具有多种药理活性的模型药物姜黄素封装到PLGA纳米颗粒中,并使用具有交错人字形结构的微流控系统研究实验条件对所得PLGA纳米颗粒的影响,该系统可通过混沌平流搅拌溶液。微流控系统中溶液的总流速和流速比会影响所得PLGA纳米颗粒的直径、多分散指数和包封效率,并产生小尺寸、均匀的PLGA纳米颗粒。将聚乙二醇(PEG)-PLGA掺入PLGA纳米颗粒中可减小粒径并提高包封效率。掺入PEG2000-PLGA可防止PLGA纳米颗粒的初始突释。负载姜黄素的聚乙二醇化PLGA纳米颗粒显示出与其他制剂相似的细胞毒性。这种微流控系统具有高通量且可扩展,可用于高效制备PLGA纳米颗粒和聚乙二醇化PLGA纳米颗粒。我们的结果将有助于利用微流控技术开发新型基于PLGA的聚合物纳米颗粒。

相似文献

1
The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.一种用于生成用于控释药物的稳定聚合物纳米颗粒的高效微流体混合系统的应用
Biol Pharm Bull. 2018;41(6):899-907. doi: 10.1248/bpb.b17-01036.
2
In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.载 IFN-α 和聚乙二醇化 IFN-α 的聚(丙交酯-乙交酯)和聚乙二醇化聚(丙交酯-乙交酯)纳米粒的体外 IFN-α 释放。
Nanomedicine (Lond). 2016 Aug;11(16):2029-34. doi: 10.2217/nnm-2016-0058. Epub 2016 Jul 27.
3
Microfluidic-assisted nanoprecipitation of (PEGylated) poly (d,l-lactic acid-co-caprolactone): Effect of macromolecular and microfluidic parameters on particle size and paclitaxel encapsulation.微流控辅助(PEG 化)聚(丙交酯-共-己内酯)的纳米沉淀:大分子和微流控参数对粒径和紫杉醇包封的影响。
Int J Pharm. 2018 Sep 5;548(1):530-539. doi: 10.1016/j.ijpharm.2018.07.031. Epub 2018 Jul 17.
4
Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1α into PLGA/PEG-PLGA nanoparticles to achieve sustained release.开发一种无毒且非变性的制剂工艺,将 SDF-1α 包封到 PLGA/PEG-PLGA 纳米粒中,以实现持续释放。
Eur J Pharm Biopharm. 2018 Apr;125:38-50. doi: 10.1016/j.ejpb.2017.12.020. Epub 2018 Jan 8.
5
pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer.具有混合核心的mPEG-PLGA-PGlu pH敏感聚合物纳米颗粒,用于同时封装姜黄素和阿霉素以杀死乳腺癌中的异质性肿瘤细胞。
Artif Cells Nanomed Biotechnol. 2018;46(sup1):302-313. doi: 10.1080/21691401.2017.1423495. Epub 2018 Jan 4.
6
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.用于更昔洛韦立体异构二肽前药持续释放的基于纳米颗粒的局部眼用制剂。
Drug Deliv. 2016 Sep;23(7):2399-2409. doi: 10.3109/10717544.2014.996833. Epub 2015 Jan 7.
7
PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.聚乙二醇-聚乳酸-羟基乙酸共聚物:结构及其影响药物递送的应用。
J Control Release. 2014 Jun 10;183:77-86. doi: 10.1016/j.jconrel.2014.03.026. Epub 2014 Mar 24.
8
A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.纯姜黄素与载姜黄素的聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒对MCF-7人乳腺癌细胞系细胞毒性作用的比较。
Artif Cells Nanomed Biotechnol. 2016;44(1):423-30. doi: 10.3109/21691401.2014.955108. Epub 2014 Sep 17.
9
Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.可生物降解的纳米架构聚乙二醇化方法可提高苯达莫司汀的稳定性和抗癌疗效。
Int J Biol Macromol. 2016 Nov;92:1242-1251. doi: 10.1016/j.ijbiomac.2016.08.004. Epub 2016 Aug 12.
10
Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS.聚合物结构对姜黄素包封及从聚乙二醇化聚合物纳米粒中释放的影响:迈向中枢神经系统药物递送纳米平台
Eur J Pharm Biopharm. 2015 Oct;96:409-20. doi: 10.1016/j.ejpb.2015.09.004. Epub 2015 Sep 25.

引用本文的文献

1
Light-responsive polymeric nanoparticles for retinal drug delivery: design cues, challenges and future perspectives.用于视网膜药物递送的光响应性聚合物纳米颗粒:设计要点、挑战与未来展望。
Heliyon. 2024 Feb 18;10(5):e26616. doi: 10.1016/j.heliyon.2024.e26616. eCollection 2024 Mar 15.
2
Sustainability in Drug and Nanoparticle Processing.药物与纳米颗粒加工中的可持续性。
Handb Exp Pharmacol. 2024;284:45-68. doi: 10.1007/164_2023_659.
3
Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery.
静态与动态微流控血管模型中尺寸依赖性聚合物纳米颗粒的分布:对基于纳米颗粒的药物递送的启示
ACS Appl Nano Mater. 2023 Apr 24;6(9):7364-7374. doi: 10.1021/acsanm.3c00481. eCollection 2023 May 12.
4
Use of Microfluidics to Prepare Lipid-Based Nanocarriers.利用微流控技术制备脂质基纳米载体。
Pharmaceutics. 2023 Mar 24;15(4):1053. doi: 10.3390/pharmaceutics15041053.
5
A review on microfluidic-assisted nanoparticle synthesis, and their applications using multiscale simulation methods.微流控辅助纳米颗粒合成及其使用多尺度模拟方法的应用综述。
Discov Nano. 2023 Feb 17;18(1):18. doi: 10.1186/s11671-023-03792-x.
6
Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.新型 PLGA/脂质纳米粒子的设计与开发作为熊果酸递送系统用于胰腺导管腺癌细胞。
Int J Mol Sci. 2022 May 16;23(10):5536. doi: 10.3390/ijms23105536.
7
Merits and advances of microfluidics in the pharmaceutical field: design technologies and future prospects.微流控技术在制药领域的优点和进展:设计技术和未来展望。
Drug Deliv. 2022 Dec;29(1):1549-1570. doi: 10.1080/10717544.2022.2069878.
8
The roadmap to micro: Generation of micron-sized polymeric particles using a commercial microfluidic system.使用商业微流控系统生成微米级聚合物颗粒的路线图。
J Biomed Mater Res A. 2022 May;110(5):1121-1133. doi: 10.1002/jbm.a.37358. Epub 2022 Jan 24.
9
Synthesis and Biodistribution of Tc-Labeled PLGA Nanoparticles by Microfluidic Technique.微流控技术制备锝标记聚乳酸-羟基乙酸共聚物纳米粒及其生物分布研究
Pharmaceutics. 2021 Oct 22;13(11):1769. doi: 10.3390/pharmaceutics13111769.
10
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide.一种小肽递送微流控方法的优化
Pharmaceutics. 2021 Sep 18;13(9):1505. doi: 10.3390/pharmaceutics13091505.